| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Bupivacaine 12.5mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules | Has active ingredient | False | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Bupivacaine 50mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection ampoules | Has active ingredient | False | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Bupivacaine 25mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules | Has active ingredient | False | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Bupivacaine 100mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,00) solution for injection ampoules | Has active ingredient | False | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Carbostesin-adrenaline 0.25% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) | Has active ingredient | False | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Carbostesin-adrenaline 0.25% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) | Has active ingredient | False | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Carbostesin-adrenaline 0.5% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) | Has active ingredient | False | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Carbostesin-adrenaline 0.5% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) | Has active ingredient | False | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Bupivacaine 12.5mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules 1 ampoule | Has active ingredient | False | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Bupivacaine 50mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection ampoules 1 ampoule | Has active ingredient | False | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Bupivacaine 25mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules 1 ampoule | Has active ingredient | False | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Bupivacaine 100mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,00) solution for injection ampoules 1 ampoule | Has active ingredient | False | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Carbostesin-adrenaline 0.25% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule | Has active ingredient | False | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Carbostesin-adrenaline 0.25% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule | Has active ingredient | False | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Carbostesin-adrenaline 0.5% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule | Has active ingredient | False | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Carbostesin-adrenaline 0.5% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule | Has active ingredient | False | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Carbostesin-adrenaline 0.5% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule | Has specific active ingredient | True | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Bupivacaine 100mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,00) solution for injection ampoules | Has specific active ingredient | True | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Carbostesin-adrenaline 0.5% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) | Has specific active ingredient | True | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Bupivacaine 100mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,00) solution for injection ampoules 1 ampoule | Has specific active ingredient | True | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Carbostesin-adrenaline 0.5% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) | Has specific active ingredient | True | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Bupivacaine 25mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules 1 ampoule | Has specific active ingredient | True | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Carbostesin-adrenaline 0.5% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule | Has specific active ingredient | True | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Bupivacaine 25mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules | Has specific active ingredient | True | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Carbostesin-adrenaline 0.25% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) | Has specific active ingredient | True | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Carbostesin-adrenaline 0.25% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule | Has specific active ingredient | True | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Bupivacaine 50mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection ampoules 1 ampoule | Has specific active ingredient | True | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Bupivacaine 50mg/20ml / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection ampoules | Has specific active ingredient | True | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Bupivacaine 12.5mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules | Has specific active ingredient | True | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Bupivacaine 12.5mg/5ml / Adrenaline 25micrograms/5ml (1 in 200,000) solution for injection ampoules 1 ampoule | Has specific active ingredient | True | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Carbostesin-adrenaline 0.25% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) | Has specific active ingredient | True | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Carbostesin-adrenaline 0.25% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules (AstraZeneca) 1 ampoule | Has specific active ingredient | True | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Bupivacaine 200mg/5ml (4%) solution for injection ampoules | Has specific active ingredient | True | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Bupivacain Sintetica 40mg/ml (4%) solution for injection ampoules (Imported (Switzerland)) | Has specific active ingredient | True | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Bupivacaine 200mg/5ml (4%) solution for injection ampoules 10 ampoule | Has specific active ingredient | True | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  | 
| Bupivacain Sintetica 40mg/ml (4%) solution for injection ampoules (Imported (Switzerland)) 10 ampoule | Has specific active ingredient | True | Bupivacaine hydrochloride anhydrous | Inferred relationship | Existential restriction modifier |  |